X-rays from the colliding wind binary WR 146

The X-ray emission from the massive binary WR 146R is analysed in the framework of the colliding stellar wind (CSW) picture. The theoretical CSW model spectra match well the shape of the observed X-ray spectrum of WR 146R but they overestimate considerably the observed X-ray flux (emission measure). This is valid both in the case of complete temperature equalization and in the case of partial electron heating at the shock fronts (different electron and ion temperatures), but, there are indications for a better correspondence between model predictions and observations for the latter. To reconcile the model predictions and observations, the mass-loss rate of WR 146 must be reduced by a factor of 8 - 10 compared to the currently accepted value for this object (the latter already takes clumping into account). No excess X-ray absorption is derived from the CSW modelling.Comment: Accepted for publication in MNRAS; 9 pages, 4 figires, 1 tabl

Integration of biological data: systems, infrastructures and programmable tools

Tesis doctoral inédita leída en la Universidad Autónoma de Madrid. Escuela Politécnica Superior, Departamento de Ingeniería informática. Fecha de lectura: 19-05-200

Network-Based Methods for Approaching Human Pathologies from a Phenotypic Point of View

Network and systemic approaches to studying human pathologies are helping us to gain insight into the molecular mechanisms of and potential therapeutic interventions for human diseases, especially for complex diseases where large numbers of genes are involved. The complex human pathological landscape is traditionally partitioned into discrete “diseases”; however, that partition is sometimes problematic, as diseases are highly heterogeneous and can differ greatly from one patient to another. Moreover, for many pathological states, the set of symptoms (phenotypes) manifested by the patient is not enough to diagnose a particular disease. On the contrary, phenotypes, by definition, are directly observable and can be closer to the molecular basis of the pathology. These clinical phenotypes are also important for personalised medicine, as they can help stratify patients and design personalised interventions. For these reasons, network and systemic approaches to pathologies are gradually incorporating phenotypic information. This review covers the current landscape of phenotype-centred network approaches to study different aspects of human diseasesThis work was partially funded by The Spanish Ministry of Economy and Competitiveness with European Regional Development Fund [grant numbers PID2019-108096RB-C21 and PID2019-108096RB-C22]; the European Food Safety Authority [grant number GP/EFSA/ENCO/2020/02]; the Andalusian Government with European Regional Development Fund [grant numbers UMA18- FEDERJA-102 and PAIDI 2020:PY20-00372]; Fundacion Progreso y Salud [grant number PI-0075-2017], also from the Andalusian Government; the Ramón Areces foundation, which funds project for the investigation of rare disease (National call for research on life and material sciences, XIX edition); the University of Malaga (Ayudas del I Plan Propio) and the Institute of Health Carlos III which funds the IMPaCT-Data project. The CIBERER is an initiative from the Institute of Health Carlos III. The conclusions, findings and opinions expressed in this scientific paper reflect only the view of the authors and not the official position of the European Food Safety Authority. Partial funding for open access charge: Universidad de Málag

La Rueda de los Inventos

Fecha de consulta: 2016-05-06N

Factors affecting interactome-based prediction of human genes associated with clinical signs

[Background] Clinical signs are a fundamental aspect of human pathologies. While disease diagnosis is problematic or impossible in many cases, signs are easier to perceive and categorize. Clinical signs are increasingly used, together with molecular networks, to prioritize detected variants in clinical genomics pipelines, even if the patient is still undiagnosed. Here we analyze the ability of these network-based methods to predict genes that underlie clinical signs from the human interactome.[Results] Our analysis reveals that these approaches can locate genes associated with clinical signs with variable performance that depends on the sign and associated disease. We analyzed several clinical and biological factors that explain these variable results, including number of genes involved (mono- vs. oligogenic diseases), mode of inheritance, type of clinical sign and gene product function.[Conclusions] Our results indicate that the characteristics of the clinical signs and their related diseases should be considered for interpreting the results of network-prediction methods, such as those aimed at discovering disease-related genes and variants. These results are important due the increasing use of clinical signs as an alternative to diseases for studying the molecular basis of human pathologies.This work has been partially funded by the Spanish Ministry of Economy and Competitiveness (Ministerio de Economía y Competividad) through grant SAF2016–78041-C2–2-R. We acknowledge support of the publication fee by the CSIC Open Access Publication Initiative through its Unit of Information Resources for Research (URICI).Peer reviewe

Applications of molecular networks in biomedicine

Due to the large interdependence between the molecular components of living systems, many phenomena, including those related to pathologies, cannot be explained in terms of a single gene or a small number of genes. Molecular networks, representing different types of relationships between molecular entities, embody these large sets of interdependences in a framework that allow their mining from a systemic point of view to obtain information. These networks, often generated from high-throughput omics datasets, are used to study the complex phenomena of human pathologies from a systemic point of view. Complementing the reductionist approach of molecular biology, based on the detailed study of a small number of genes, systemic approaches to human diseases consider that these are better reflected in large and intricate networks of relationships between genes. These networks, and not the single genes, provide both better markers for diagnosing diseases and targets for treating them. Network approaches are being used to gain insight into the molecular basis of complex diseases and interpret the large datasets associated with them, such as genomic variants. Network formalism is also suitable for integrating large, heterogeneous and multilevel datasets associated with diseases from the molecular level to organismal and epidemiological scales. Many of these approaches are available to nonexpert users through standard software packages.This work was partially supported by the Spanish Ministry of Economy and Competitiveness with European Regional Development Fund [SAF2016-78041-C2-1-R to J.A.G.R. and SAF2016–78041-C2–2-RtoF.P.]and the Andalusian Government with European Regional Development Fund[CTS-486] to J.A.G.R. The CIBERER is an initiative of the Instituto de Salud Carlos III

MBRole: Enrichment analysis of metabolomic data

Summary: While many tools exist for performing enrichment analysis of transcriptomic and proteomic data in order to interpret them in biological terms, almost no equivalent tools exist for metabolomic data. We present Metabolite Biological Role (MBRole), a web server for carrying out over-representation analysis of biological and chemical annotations in arbitrary sets of metabolites (small chemical compounds) coming from metabolomic data of any organism or sample. © The Author 2011. Published by Oxford University Press. All rights reserved.Spanish Ministry for Science and Innovation (project number BIO2009-11966, in part).Peer Reviewe

Complex genetic and epigenetic regulation deviates gene expression from a unifying global transcriptional program

© 2019 Chagoyen, Poyatos. TEnvironmental or genetic perturbations lead to gene expression changes. While most analyses of these changes emphasize the presence of qualitative differences on just a few genes, we now know that changes are widespread. This large-scale variation has been linked to the exclusive influence of a global transcriptional program determined by the new physiological state of the cell. However, given the sophistication of eukaryotic regulation, we expect to have a complex architecture of specific control affecting this program. Here, we examine this architecture. Using data of Saccharomyces cerevisiae expression in different nutrient conditions, we first propose a five-sector genome partition, which integrates earlier models of resource allocation, as a framework to examine the deviations from the global control. In this scheme, we recognize invariant genes, whose regulation is dominated by physiology, specific genes, which substantially depart from it, and two additional classes that contain the frequently assumed growth-dependent genes. Whereas the invariant class shows a considerable absence of specific regulation, the rest is enriched by regulation at the level of transcription factors (TFs) and epigenetic modulators. We nevertheless find markedly different strategies in how these classes deviate. On the one hand, there are TFs that act in a unique way between partition constituents, and on the other, the action of chromatin modifiers is significantly diverse. The balance between regulatory strategies ultimately modulates the action of the general transcription machinery and therefore limits the possibility of establishing a unifying program of expression change at a genomic scale.This work was supported by grant FIS2016-78781-R and the Salvador de Madariaga program (grant PRX18/00439) from the Spanish Ministerio de Economía y Competitividad (JFP)

Complex genetic and epigenetic regulation deviates gene expression from a unifying global transcriptional program.

Environmental or genetic perturbations lead to gene expression changes. While most analyses of these changes emphasize the presence of qualitative differences on just a few genes, we now know that changes are widespread. This large-scale variation has been linked to the exclusive influence of a global transcriptional program determined by the new physiological state of the cell. However, given the sophistication of eukaryotic regulation, we expect to have a complex architecture of specific control affecting this program. Here, we examine this architecture. Using data of Saccharomyces cerevisiae expression in different nutrient conditions, we first propose a five-sector genome partition, which integrates earlier models of resource allocation, as a framework to examine the deviations from the global control. In this scheme, we recognize invariant genes, whose regulation is dominated by physiology, specific genes, which substantially depart from it, and two additional classes that contain the frequently assumed growth-dependent genes. Whereas the invariant class shows a considerable absence of specific regulation, the rest is enriched by regulation at the level of transcription factors (TFs) and epigenetic modulators. We nevertheless find markedly different strategies in how these classes deviate. On the one hand, there are TFs that act in a unique way between partition constituents, and on the other, the action of chromatin modifiers is significantly diverse. The balance between regulatory strategies ultimately modulates the action of the general transcription machinery and therefore limits the possibility of establishing a unifying program of expression change at a genomic scale

Quantifying the biological significance of gene ontology biological processes--implications for the analysis of systems-wide data.

MOTIVATION: Gene Ontology (GO), the de facto standard for representing protein functional aspects, is being used beyond the primary goal for which it is designed: protein functional annotation. It is increasingly used to evaluate large sets of relationships between proteins, e.g. protein-protein interactions or mRNA co-expression, under the assumption that related proteins tend to have the same or similar GO terms. Nevertheless, this assumption only holds for terms representing functional groups with biological significance ('classes'), and not for the ones representing human-imposed aggregations or conceptualizations lacking a biological rationale ('categories'). RESULTS: Using a data-driven approach based on a set of high-quality functional associations, we quantify the functional coherence of GO biological process (GO:BP) terms as well as their explicit and implicit relationships, trying to distinguish classes and categories. We show that the quantification used is in agreement with the distinction one would intuitively make between these two concepts. As not all GO:BP terms and relationships are equally supported by current functional associations, any detailed validation of new experimental data using GO:BP, beyond whole-system statistics, should take such unbalance into account. SUPPLEMENTARY INFORMATION: Supplementary data are available at Bioinformatics online.Spanish Ministry for Education and Science (project number BIO2006-15318).Peer Reviewe